H. B. Fuller (NYSE:FUL) Updates FY 2026 Earnings Guidance

H. B. Fuller (NYSE:FUL) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 4.550-4.900 for the period, compared to the consensus estimate of 4.560. The company issued revenue guidance of -.

H. B. Fuller Price Performance

FUL opened at $63.86 on Friday. The company has a market capitalization of $3.48 billion, a price-to-earnings ratio of 21.08, a P/E/G ratio of 0.83 and a beta of 1.05. H. B. Fuller has a 1 year low of $48.71 and a 1 year high of $68.63. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.92 and a quick ratio of 1.15. The firm’s fifty day moving average price is $61.21 and its two-hundred day moving average price is $60.01.

H. B. Fuller (NYSE:FUL) last issued its earnings results on Wednesday, March 25th. The specialty chemicals company reported $0.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.56 by $0.01. The business had revenue of $770.84 million during the quarter, compared to analyst estimates of $787.77 million. H. B. Fuller had a return on equity of 11.84% and a net margin of 4.62%.H. B. Fuller’s revenue for the quarter was down 2.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.54 earnings per share. As a group, analysts anticipate that H. B. Fuller will post 4.07 earnings per share for the current fiscal year.

H. B. Fuller Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, February 19th. Investors of record on Thursday, February 5th were paid a $0.235 dividend. This represents a $0.94 annualized dividend and a yield of 1.5%. The ex-dividend date of this dividend was Thursday, February 5th. H. B. Fuller’s dividend payout ratio (DPR) is presently 31.02%.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on FUL. Vertical Research raised H. B. Fuller from a “hold” rating to a “strong-buy” rating in a research report on Friday, March 27th. Wall Street Zen upgraded shares of H. B. Fuller from a “hold” rating to a “buy” rating in a research note on Sunday, March 29th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of H. B. Fuller in a research note on Friday, January 16th. UBS Group lowered their price objective on shares of H. B. Fuller from $66.00 to $63.00 and set a “neutral” rating on the stock in a research note on Friday, March 27th. Finally, Citigroup increased their price objective on shares of H. B. Fuller from $67.00 to $70.00 and gave the company a “buy” rating in a research note on Monday, March 30th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $65.50.

Insider Transactions at H. B. Fuller

In related news, CEO Celeste Beeks Mastin acquired 5,170 shares of H. B. Fuller stock in a transaction that occurred on Tuesday, April 7th. The shares were purchased at an average cost of $57.08 per share, for a total transaction of $295,103.60. Following the acquisition, the chief executive officer owned 8,670 shares in the company, valued at approximately $494,883.60. This represents a 147.71% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 1.83% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On H. B. Fuller

Institutional investors have recently made changes to their positions in the company. Dimensional Fund Advisors LP lifted its holdings in shares of H. B. Fuller by 2.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,475,448 shares of the specialty chemicals company’s stock valued at $147,193,000 after buying an additional 61,102 shares during the period. Victory Capital Management Inc. increased its stake in shares of H. B. Fuller by 5.7% in the 4th quarter. Victory Capital Management Inc. now owns 1,228,068 shares of the specialty chemicals company’s stock valued at $73,021,000 after buying an additional 66,686 shares during the period. Wellington Management Group LLP lifted its stake in shares of H. B. Fuller by 3.6% in the 3rd quarter. Wellington Management Group LLP now owns 976,005 shares of the specialty chemicals company’s stock valued at $57,858,000 after acquiring an additional 33,522 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in H. B. Fuller by 4.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 879,199 shares of the specialty chemicals company’s stock worth $52,277,000 after acquiring an additional 37,077 shares during the period. Finally, UBS Group AG grew its stake in shares of H. B. Fuller by 200.8% in the 3rd quarter. UBS Group AG now owns 820,871 shares of the specialty chemicals company’s stock valued at $48,661,000 after buying an additional 548,017 shares during the period. 95.93% of the stock is currently owned by institutional investors.

H. B. Fuller Company Profile

H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.

Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.